A New Cytochrome P450 Form Belonging to the CYP2D in Dog Liver Microsomes: Purification, cDNA Cloning, and Enzyme Characterization

doi:10.1006/abbi.1995.1307

Archives of Biochemistry and Biophysics

Volume 319, Issue 2, 10 June 1995, Pages 372-382

https://doi.org/10.1006/abbi.1995.1307 Get rights and content

Abstract

A new form of cytochrome P450 (P450 DUT2) was purified from untreated male dog liver microsomes. The final preparation (a specific content of 19.1 nmol P450/mg protein) showed a single band with an apparent monomeric molecular weight of 50,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, but was further separated into two apoproteins (P450 DUT2_a and P450 DUT2_b) by reverse-phase HPLC. Both proteins had identical NH₂-terminal amino acid sequences, but the first three amino acids of P450 DUT2_b were truncated in P450 DUT2_a. Purified P450 DUT2 showed 5 to 18 times higher catalytic activities than did hepatic microsomes toward desipramine, metoprolol, and dextromethorphan. These activities in dog liver microsomes were strongly inhibited by anti-P450 DUT2-IgG. A 1.7-kilobase pair cDNA (cDUT2) encoding a male dog liver P450 of 500 amino acid residues (molecular weight 56,400) was isolated and sequenced. The first 35 NH₂-terminal amino acid sequence of P450 DUT2_b coincided with the deduced amino acid sequence of cDUT2 at 2-36. The deduced total amino acid sequence of cDUT2 shared high similarity with the reported 2D forms (with 2D6, 74.6%; 2D14, 75.4%; 2D1, 65.4%; and 2D9, 63.6%). Moreover, the expressed P450 DUTS in COS-7 cells had catalytic activities similar to those of purified P450 DUT2. Therefore, this paper is the first report about dog CYP2D. Furthermore, Northern and Western blot analyses indicated that the expressed levels of mRNA and protein were almost equal between male and female dogs. Western blot analysis suggested that P450 DUT2 is a constitutive and major (approximately 20% of the total P450) form, indicating that the 2D subfamily P450 in dog Liver is quite unique from CYP2D members of other species.

References (0)

Cited by (56)

A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models
2024, Biochemical Pharmacology
Drug oxygenation is mainly mediated by cytochromes P450 (P450s, CYPs) and flavin-containing monooxygenases (FMOs). Polymorphic variants of P450s and FMOs are known to influence drug metabolism.　Species differences exist in terms of drug metabolism and can be important when determining the contributions of individual enzymes. The success of research into drug-metabolizing enzymes and their impacts on drug discovery and development has been remarkable. Dogs and pigs are often used as preclinical animal models. This research update provides information on P450 and FMO enzymes in dogs and pigs and makes comparisons with their human enzymes. Newly identified dog CYP3A98, a testosterone 6β- and estradiol 16α-hydroxylase, is abundantly expressed in small intestine and is likely the major CYP3A enzyme in small intestine, whereas dog CYP3A12 is the major CYP3A enzyme in liver. The roles of recently identified dog CYP2J2 and pig CYP2J33/34/35 were investigated. FMOs have been characterized in humans and several other species including dogs and pigs. P450 and FMO family members have been characterized also in cynomolgus macaques and common marmosets. P450s have industrial applications and have been the focus of attention of many pharmaceutical companies. The techniques used to investigate the roles of P450/FMO enzymes in drug oxidation and clinical treatments have not yet reached maturity and require further development. The findings summarized here provide a foundation for understanding individual pharmacokinetic and toxicological results in dogs and pigs as preclinical models and will help to further support understanding of the molecular mechanisms of human P450/FMO functionality.
Electrochemistry of Canis familiaris cytochrome P450 2D15 with gold nanoparticles: An alternative to animal testing in drug discovery
2015, Bioelectrochemistry
Citation Excerpt :
On the other hand, the enzyme immobilized in the presence of AuNps (GC/AuNPs/2D15) was capable of hydroxylating the metoprolol producing 30.7 ± 2.3 pmol of product at the higher metoprolol concentrations used. No O-desmethylated product was observed in line with previously published data on microsomal P450 2D15 [28]. Control experiments were also carried out in the absence of the protein and as expected no product was detected (data not shown).
This work reports for the first time the direct electron transfer of the Canis familiaris cytochrome P450 2D15 on glassy carbon electrodes to provide an analytical tool as an alternative to P450 animal testing in the drug discovery process. Cytochrome P450 2D15, that corresponds to the human homologue P450 2D6, was recombinantly expressed in Escherichia coli and entrapped on glassy carbon electrodes (GC) either with the cationic polymer polydiallyldimethylammonium chloride (PDDA) or in the presence of gold nanoparticles (AuNPs). Reversible electrochemical signals of P450 2D15 were observed with calculated midpoint potentials (E_1/2) of − 191 ± 5 and − 233 ± 4 mV vs. Ag/AgCl for GC/PDDA/2D15 and GC/AuNPs/2D15, respectively.
These experiments were then followed by the electro-catalytic activity of the immobilized enzyme in the presence of metoprolol. The latter drug is a beta-blocker used for the treatment of hypertension and is a specific marker of the human P450 2D6 activity. Electrocatalysis data showed that only in the presence of AuNps the expected α-hydroxy-metoprolol product was present as shown by HPLC.
The successful immobilization of the electroactive C. familiaris cytochrome P450 2D15 on electrode surfaces addresses the ever increasing demand of developing alternative in vitro methods for a more detailed study of animal P450 enzymes' metabolism, reducing the number of animals sacrificed in preclinical tests.
Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants
2022, Genetica
Analysis of polymorphisms of canine Cytochrome P 450-CYP2D15
2020, Journal of Veterinary Pharmacology and Therapeutics
Personalized medicine: going to the dogs?
2019, Human Genetics
Species differences in metabolism of EPZ015666, an oxetane-containing protein arginine methyltransferase-5 (PRMT5) inhibitor
2016, Xenobiotica

View all citing articles on Scopus

View full text

Regular ArticleA New Cytochrome P450 Form Belonging to the CYP2D in Dog Liver Microsomes: Purification, cDNA Cloning, and Enzyme Characterization

Abstract

Regular Article
A New Cytochrome P450 Form Belonging to the CYP2D in Dog Liver Microsomes: Purification, cDNA Cloning, and Enzyme Characterization